HVO Stock Overview
hVIVO plc operates as a pharmaceutical service and contract research company.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
hVIVO plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.32 |
| 52 Week High | UK£0.36 |
| 52 Week Low | UK£0.16 |
| Beta | 1.01 |
| 1 Month Change | 0% |
| 3 Month Change | 5.96% |
| 1 Year Change | n/a |
| 3 Year Change | -27.27% |
| 5 Year Change | n/a |
| Change since IPO | 146.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| HVO | IE Life Sciences | IE Market | |
|---|---|---|---|
| 7D | -8.6% | -9.9% | 0.4% |
| 1Y | n/a | -14.9% | 14.6% |
Return vs Industry: Insufficient data to determine how HVO performed against the Irish Life Sciences industry.
Return vs Market: Insufficient data to determine how HVO performed against the Irish Market.
Price Volatility
| HVO volatility | |
|---|---|
| HVO Average Weekly Movement | 3.9% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in IE Market | 5.7% |
| 10% least volatile stocks in IE Market | 2.8% |
Stable Share Price: HVO has not had significant price volatility in the past 3 months.
Volatility Over Time: HVO's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 274 | Mo Khan | www.hvivo.com |
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing of vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations.
hVIVO plc Fundamentals Summary
| HVO fundamental statistics | |
|---|---|
| Market cap | €216.98m |
| Earnings (TTM) | €18.69m |
| Revenue (TTM) | €68.03m |
11.6x
P/E Ratio3.2x
P/S RatioIs HVO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HVO income statement (TTM) | |
|---|---|
| Revenue | UK£58.67m |
| Cost of Revenue | UK£45.63m |
| Gross Profit | UK£13.04m |
| Other Expenses | -UK£3.08m |
| Earnings | UK£16.12m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 22.22% |
| Net Profit Margin | 27.47% |
| Debt/Equity Ratio | 0% |
How did HVO perform over the long term?
See historical performance and comparison